Review Article| Volume 43, ISSUE 2, P389-397, April 2010

Evaluation of Hypercalcemia in Relation to Hyperparathyroidism


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Otolaryngologic Clinics of North America
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Frolich A.
        Prevalence of hypercalcemia in normal and hospitalized populations.
        Dan Med Bull. 1998; 45: 436-439
        • Mundy F.R.
        • Guise T.A.
        Hormonal control of calcium homeostasis.
        Clin Chem. 1999; 45: 1347-1352
        • Brown E.M.
        • Pollak M.
        • Seidman C.E.
        • et al.
        Calcium-ion-sensing cell-surface receptors.
        N Engl J Med. 1995; 333: 234-240
        • Marx S.J.
        • Attie M.F.
        • Levine M.A.
        • et al.
        The hypercalciuric or benign variant of familial hypercalcemia: clinical and biochemical features of in fifteen kindreds.
        Medicine. 1981; 60: 397-412
        • Grill V.
        • Ho P.
        • Body J.J.
        • et al.
        Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.
        J Clin Endocrinol Metab. 1991; 73: 1309-1315
        • Ikeda K.
        • Ohno H.
        • Hane M.
        • et al.
        Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma.
        J Clin Endocrinol Metab. 1994; 79: 1322-1327
        • Nagai Y.
        • Yamato H.
        • Akogi K.
        • et al.
        Role of interleukin 6 in uncoupling of bone in vivo in a human squamous carcinoma co-producing PTHrp and interleukin 6.
        J Bone Miner Res. 1998; 13: 664-672
        • Breslau N.A.
        • McGuire J.L.
        • Zerwekh J.E.
        • et al.
        Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma.
        Ann Intern Med. 1984; 100: 1-7
        • Rosenthal N.R.
        • Insogna K.L.
        • Godsall J.W.
        • et al.
        Elevations in circulating 1,25(OH)2D in three patients with lymphoma-associated hypercalcemia.
        J Clin Endocrinol Metab. 1985; 60: 29-33
        • Adams J.S.
        • Fernandez M.
        • Gacad M.A.
        • et al.
        Vitamin D metabolite mediated hypercalcemia and hypercalciuria in patients with AIDS and non-AIDS-associated lymphoma.
        Blood. 1989; 73: 235-239
        • Seymour J.F.
        • Gagel R.F.
        Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas.
        Blood. 1993; 82: 1383-1394
        • Mundy G.R.
        • Yoneda T.
        • Guise T.A.
        Hypercalcemia in hematologic malignancies and in solid tumors associated with extensive localized bone destruction.
        in: Favus M.J. Primer on metabolic bone diseases and disorders of mineral metabolism. 4th edition. Lippencott Williams and Wilkins, Philadelphia1999: 183-187
        • Knecht T.P.
        • Behling C.A.
        • Burton D.W.
        • et al.
        The humoral hypercalcemia of benignancy. A newly appreciated syndrome.
        Am J Clin Pathol. 1996; 105: 487-492
        • Burman K.D.
        • Monchick J.M.
        • Earll J.M.
        • et al.
        Ionized and total serum calcium and parathyroid hormone in hyperparathyroidism.
        Ann Intern Med. 1976; 84: 668-671
        • Stewart A.F.
        • Hoecker J.
        • Segre G.V.
        • et al.
        Hypercalcemia in pheochromocytoma: evidence for a novel mechanism.
        Ann Intern Med. 1985; 102: 776-779
        • Mune T.
        • Katakami H.
        • Kato Y.
        • et al.
        Production and secretion of parathyroid hormone-related protein in pheochromocytoma: participation of an α-adrenergic mechanism.
        J Clin Endocrinol Metab. 1993; 76: 757-762
        • Adams J.S.
        • Singer F.R.
        • Gacad M.A.
        • et al.
        Isolation and structural identification of 1,25-dihyroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis.
        J Clin Endocrinol Metab. 1985; 60: 960-966
        • Edelson G.W.
        • Talpos G.B.
        • Bone III, H.G.
        Hypercalcemia associated with Wegener's granulomatosis and hyperparathyroidism: etiology and management.
        Am J Nephrol. 1993; 13: 275-277
        • Stoeckle J.D.
        • Hardy H.L.
        • Weber A.L.
        Chronic beryllium disease: long-term follow-up of sixty cases and selective review of the literature.
        Am J Med. 1969; 46: 545-561
        • Parker M.S.
        • Dokoh S.
        • Woolfenden J.M.
        • et al.
        Hypercalcemia in coccidioidomycosis.
        Am J Med. 1983; 74: 721-724
        • Tominaga Y.
        • Takagi H.
        Molecular genetics of hyperparathyroidism disease.
        Curr Opin Nephrol Hypertens. 1996; 5: 336-341